Sponsored by:

Molecular Imaging: Page 310

Contrast CT, PET/CT assess cancer therapy for melanoma
By Wayne Forrest
Dynamic contrast-enhanced CT and FDG-PET/CT can provide additional information to evaluate and confirm how well melanoma patients respond to immune-modulated and antiangiogenic cancer therapy, according to researchers from Dana-Farber Cancer Institute.
January 10, 2012
U. of Iowa suspends pay for physician
By AuntMinnie.com staff writers
The University of Iowa has suspended salary payments to a nuclear medicine physician who has been embroiled in a personnel dispute with the school.
January 9, 2012
IBA spins out radiopharma division
By AuntMinnie.com staff writers
Ion Beam Applications (IBA) has spun off its radiopharmaceutical business into a standalone firm, with a majority interest in the company controlled by SK Capital Partners, a New York City-based private investment firm. The firms are renaming the new company as IBA Molecular Imaging.
January 8, 2012
GE nets FDA nod for SPECT system
By AuntMinnie.com staff writers
GE Healthcare has received U.S. Food and Drug Administration clearance for its Brivo NM615 single-head nuclear medicine gamma camera.
January 8, 2012
FDG-PET highly useful in dementia detection
By AuntMinnie.com staff writers
An analysis of research from 1999 to 2010 shows PET achieved overall accuracy of 86% in safely and accurately detecting dementia and Alzheimer's disease, according to a new study in the January issue of the Journal of Nuclear Medicine.
January 8, 2012
PiB-PET finds exercise reduces Alzheimer's risk
By AuntMinnie.com staff writers
PET imaging with carbon-11-labeled Pittsburgh Compound B (PiB) has shown that a sedentary lifestyle is associated with greater cerebral amyloid deposition among cognitively normal individuals with the ε4 allele of the apolipoprotein E gene, according to a report published online January 9 in Archives of Neurology.
January 8, 2012
Medical isotope bill advances in Congress
By AuntMinnie.com staff writers
The American Medical Isotopes Production Act of 2011 is now in the U.S. House of Representatives following U.S. Senate passage of the bill in November.
January 5, 2012
Study of DRA's impact paints a complex picture
By Kate Madden Yee
The Deficit Reduction Act (DRA) took a meat cleaver to reimbursement at U.S. outpatient imaging facilities when it went into effect in 2006. DRA opponents predicted that the law would force private imaging centers to close, shift imaging to less-convenient hospital settings, and reduce access to seniors. But has that really happened?
January 5, 2012
2012 01 05 14 57 13 847 Levin Dra Table1 450
Bracco ramps up for CardioGen relaunch; cancer deaths fall in U.S.
By Brian Casey
January 4, 2012
Neoprobe completes name change to Navidea
By AuntMinnie.com staff writers
Radiopharmaceutical developer Neoprobe has completed the company's name change to Navidea Biopharmaceuticals.
January 4, 2012
Neoprobe lands $10M financing
By AuntMinnie.com staff writers
Radiopharmaceutical developer Neoprobe has secured $10 million in debt financing from specialty finance firm Hercules Technology Growth Capital.
January 4, 2012
Bracco to return CardioGen PET tracer to market in Q1
By Wayne Forrest
Contrast agent developer Bracco Diagnostics anticipates that shipments of its CardioGen-82 cardiac PET radiopharmaceutical will resume by the end of the first quarter, after the company voluntarily recalled the product six months ago.
January 4, 2012
2012 01 04 15 15 30 885 Cardio Gen Mild Il Ischemia Thumb
Previous Page
Page 310 of 612
Next Page